All News

2019

September

Media Release / Sep 05, 2019

Novartis study shows migraine support in the workplace can improve employee quality of life

Read More
Media Release / Sep 03, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More
Media Release / Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Read More
Media Release / Sep 01, 2019

Novartis PARAGON-HF trial suggests Entresto® benefit in HFpEF patients but narrowly misses primary endpoint

Read More

August

Cynthia, a lady living with heart failure
Story / Aug 30, 2019

Living with HFpEF – a patient’s story

Cynthia lives with Heart Failure with preserved Ejection Fraction, a complex and challenging condition.

Read More
Media Release / Aug 30, 2019

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

Read More
Patient leaving hospital with family
Featured News / Aug 26, 2019

Blood Cancer Awareness Month - Cutting Edge Innovation in Hematology

Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.

Read More
Street scene in Capetown, South Africa
Featured News / Aug 19, 2019

Impact Measurement and Valuation

Novartis joins seven global companies to found the Value Balancing Alliance

Read More
Media Release / Aug 19, 2019

Novartis to present new Entresto HFpEF and HFrEF data at ESC Congress 2019

Read More
Shamsah Kazani splits her time between two cities in the US
Story / Aug 15, 2019

Flexibility at Novartis: Shamsah Kazani

Kazani describes how her flexible work arrangement helps her balance her personal and professional lives.

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More